Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is G  [Clear All Filters]
Li Y, Li J, Zhou T, Pan G, Huang K. Generation of PARP1 gene knockout human embryonic stem cell line using CRISPR/Cas9. Stem Cell Res. 2021;53:102288.
Ma L, Prada AM, Schmidt M, Morrow EM. Generation of pathogenic TPP1 mutations in human stem cells as a model for neuronal ceroid lipofuscinosis type 2 disease. Stem Cell Res. 2021;53:102323.
Wu J, Ren J, Luo H, Zuo X, Tang Y. Generation of patient-specific induced pluripotent stem cell line (CSUi002-A) from a patient with isolated dystonia carrying TOR1A mutation. Stem Cell Res. 2021;53:102277.
Mutukula N, Man Z, Takahashi Y, Martinez FIniesta, Morales M, Carreon-Guarnizo E, Clares RHernandez, García-Bernal D, Martinez LMartinez, Lajara J, et al. Generation of RRMS and PPMS specific iPSCs as a platform for modeling Multiple Sclerosis. Stem Cell Res. 2021;53:102319.
Qin Y, Wong B, Zhong L, Geng F, Parada LF, Wen D. Generation of Sex-Reversed Female Clonal Mice via CRISPR-Cas9-Mediated Y Chromosome Deletion in Male Embryonic Stem Cells. CRISPR J. 2021.
Pandolfi EC, Sosa E, Hunt TJ, Goldsmith S, Hurlbut K, Silber SJ, Clark AT. Generation of six human induced pluripotent stem cell sublines (MZT01E, MZT01F, MZT01N and MZT02D, MZT02G and MZT02H) for reproductive science research. Stem Cell Res. 2021;51:102204.
Hedges EC, Topp S, Shaw CE, Nishimura AL. Generation of six induced pluripotent stem cell lines from patients with amyotrophic lateral sclerosis with associated genetic mutations in either FUS or ANXA11. Stem Cell Res. 2021;52:102246.
He L, Han X, Zhao H, Li S, Chen Z, Wang C, Wang S, Peng L, Deng W, Li Z, et al. Generation of spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cell line (CSUXHi005-A) from human urine epithelial cells. Stem Cell Res. 2021;53:102289.
Ko EJeong, Cui S, Shin YJin, Lim SWoo, Lee KIn, Lee JYoung, Yang CWoo, Kim M, Chung BHa. Generation of the human induced pluripotent stem cell lines (CMCi009-A) from a patient with Birt-Hogg-Dubé syndrome (BHD) with heterozygous frameshift deletion mutation c.1285delC of the FLCN gene. Stem Cell Res. 2021;51:102215.
Cañibano-Hernández A, Valdes-Sanchez L, Garcia-Delgado AB, Ponte-Zuñiga B, Díaz-Corrales FJ, De la Cerda B. Generation of the human iPSC line ESi082-A from a patient with macular dystrophy associated to mutations in the CRB1 gene. Stem Cell Res. 2021;53:102301.
Wu H, Wang G, Gao E, Zhao J, Zhang L, Chen L, Zhu Y, Zhang J, Liu Z. Generation of the induced pluripotent stem cell line (NCKDi002-A) from a 22-year-old patient with Focal Segmental Glomerular Sclerosis carrying a heterozygous mutation in WT1 gene. Stem Cell Res. 2021;53:102293.
Jahng JWS, Black KE, Liu L, Bae HRyeong, Perez M, Ashley EA, Sallam K, Wu JC. Generation of three induced pluripotent stem cell lines, SCVIi003-A, SCVIi004-A, SCVIi005-A, from patients with ARVD/C caused by heterozygous mutations in the PKP2 gene. Stem Cell Res. 2021;53:102284.
Zhang W, Dai Q, Hua Y, Di W, Guo J, Zhao J, Deng Y, Wang Y. Generation of three iPSC cell lines (SIAISi006-A, SIAISi007-A and SIAISi008-A) from a 66-year-old Alzheimer's disease (AD) patient and her two unaffected children from Chinese Han population. Stem Cell Res. 2021;51:102172.
Ramme APatricia, Faust D, Koenig L, Nguyen N, Marx U. Generation of two additional integration-free iPSC lines from related human donors. Stem Cell Res. 2021;53:102327.
Schmid B, Holst B, Poulsen U, Jørring I, Clausen C, Rasmussen M, Mau-Holzmann UA, Steeg R, Nuthall H, Ebneth A, et al. Generation of two gene edited iPSC-lines carrying a DOX-inducible NGN2 expression cassette with and without GFP in the AAVS1 locus. Stem Cell Res. 2021;52:102240.
Liu L, Shenoy SP, Jahng JWS, Liu Y, Knowles JW, Zhuge Y, Wu JC. Generation of two heterozygous MYBPC3 mutation-carrying human iPSC lines, SCVIi001-A and SCVIi002-A, for modeling hypertrophic cardiomyopathy. Stem Cell Res. 2021;53:102279.
Kuramochi Y, Awaya T, Matsuo-Takasaki M, Takami M, An Y, Li J, Hemmi Y, Wakabayashi T, Arai Y, Inoue J, et al. Generation of two human induced pluripotent stem cell lines derived from two X-linked adrenoleukodystrophy patients with ABCD1 mutations. Stem Cell Res. 2021;53:102337.
Peron C, Mauceri R, Iannielli A, Cavaliere A, Legati A, Rizzo A, Sciacca FL, Broccoli V, Tiranti V. Generation of two human iPSC lines, FINCBi002-A and FINCBi003-A, carrying heteroplasmic macrodeletion of mitochondrial DNA causing Pearson's syndrome. Stem Cell Res. 2021;50:102151.
Zhang D, McLenachan S, Chen S-C, Zaw K, Alziyadat Y, Zhang X, Lamey TM, Thompson JA, McLaren TL, Mellough C, et al. Generation of two induced pluripotent stem cell lines from a patient with recessive inherited retinal disease caused by compound heterozygous mutations in SNRNP200. Stem Cell Res. 2021;51:102154.
Liu R, Qian K, Xiao Y, Jiang W. Generation of two induced pluripotent stem cell lines from blood cells of a prostate cancer patient carrying germline mutation in CHEK2. Stem Cell Res. 2021;53:102299.
Ma Y, Wang Z, Gao M, Liu X, Sun W, Gong Y, Sun G, Liu G. Generation of two induced pluripotent stem cell lines from patients with X-linked Alport syndrome. Stem Cell Res. 2021;53:102343.
Kondrateva E, Demchenko A, Slesarenko Y, Pozhitnova V, Yasinovsky M, Amelina E, Tabakov V, Voronina E, Lavrov A, Smirnikhina S. Generation of two induced pluripotent stem cell lines (RCMGi004-A and -B) from human skin fibroblasts of a cystic fibrosis patient with compound heterozygous F508del/W1282X mutations in CFTR gene. Stem Cell Res. 2021;52:102232.
Li B, Ye F, Chen L, Yang X, Zhang J, Luo Y, Xu J, Luo Y, Wang S. Generation of two induced pluripotent stem cell lines SPPHi001-A and SPPHi002-A from a Huntington's disease family of Southwestern China. Stem Cell Res. 2021;50:102149.
Merkert S, Wunderlich S, Beier J, Franke A, Schwanke K, Göhring G, Kraft T, Francino A, Zweigerdt R, Martin U. Generation of two iPSC clones (MHHi021-A and MHHi021-B) from a patient with hypertrophic cardiomyopathy with p.Arg723Gly mutation in the MYH7 gene. Stem Cell Res. 2021;52:102208.
Fukunaga I, Oe Y, Danzaki K, Ohta S, Chen C, Iizumi M, Shiga T, Matsuoka R, Anzai T, Hibiya-Motegi R, et al. Generation of two iPSC lines from siblings of a homozygous patient with hearing loss and a heterozygous carrier with normal hearing carrying p.G45E/Y136X mutation in GJB2. Stem Cell Res. 2021;53:102290.